These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aspects of the pharmacology of phenytoin (dilantin) and phenobarbital relevant to their dosage in the treatment of epilepsy. BUCHTHAL F; SVENSMARK O Epilepsia; 1960 Jun; 1():373-84. PubMed ID: 13849222 [No Abstract] [Full Text] [Related]
4. What comes after dilantin? UNIKER TE Psychoanal Rev; 1950 Oct; 37(4):363-4. PubMed ID: 14827987 [No Abstract] [Full Text] [Related]
5. [Effect of dilantin on the frequency of epileptic convulsive attacks]. KALINER SS Nevropatol Psikhiatriia; 1950; 19(5):50-2. PubMed ID: 14775838 [No Abstract] [Full Text] [Related]
6. The mode of action of sodium diphenylhydantoinate (dilantin) in epilepsy. AIRD RB; STRAIT L J Pharmacol Exp Ther; 1951 Oct; 103(2):136-46. PubMed ID: 14881076 [No Abstract] [Full Text] [Related]
7. Treatment of epilepsy with diphenylhydantoin sodium (dilantin sodium). LIVINGSTON S Postgrad Med; 1956 Dec; 20(6):584-90. PubMed ID: 13379111 [No Abstract] [Full Text] [Related]
8. Comparative results in seizure control using phenobarbital, dilantin, and mesantoin. RUSKIN DB Am J Psychiatry; 1950 Dec; 107(6):415-21. PubMed ID: 14838144 [No Abstract] [Full Text] [Related]
9. Dilantin toxicity. A clinical and electroence-phalographic study. ROSEMAN E Neurology; 1961 Oct; 11():912-21. PubMed ID: 13743310 [No Abstract] [Full Text] [Related]
10. Hypertrichosis occurring in association with dilantin therapy. LIVINGSTON S; PETERSEN D; BOKS LL J Pediatr; 1955 Sep; 47(3):351-2. PubMed ID: 13252529 [No Abstract] [Full Text] [Related]
11. [Use of parenteral dilantin sodium in control of neurosurgical convulsive seizure]. FUKAI H; WATANABE S; NAKAI S; SATO S No To Shinkei; 1962 Jan; 14():67-72. PubMed ID: 13895781 [No Abstract] [Full Text] [Related]
12. Use of parenteral diphenylhydantoin (dilantin) sodium in control of status epilepticus. CARTER CH AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):136-7. PubMed ID: 13497354 [No Abstract] [Full Text] [Related]
13. Fatal granulocytopenia following hydantoins, mesantoin and dilantin; report of a case. BERNHARDT H J Med Assoc State Ala; 1950 Jan; 19(7):193-7. PubMed ID: 15408514 [No Abstract] [Full Text] [Related]
15. The combined anticonvulsant activity and toxicity of dilantin and N-methyl-5-phenylsuccinimide. CHEN G; ENSOR CR J Lab Clin Med; 1953 Jan; 41(1):78-83. PubMed ID: 13023097 [No Abstract] [Full Text] [Related]
16. Dermal chemical response to analogues of dilantin. HOUCK JC J Invest Dermatol; 1963 Feb; 40():89-93. PubMed ID: 13955035 [No Abstract] [Full Text] [Related]
17. The use of 3,-methyl,5,phenylhydantoin (AC 114) in the treatment of epilepsy (a preliminary report). LIVINSTON S; SWEET AY Bull Johns Hopkins Hosp; 1950 Jun; 86(6):359-63. PubMed ID: 15420547 [No Abstract] [Full Text] [Related]
18. Megaloblastic anemia due to dilantin therapy. LUSTBERG A; GOLDMAN D; DRESKIN OH Ann Intern Med; 1961 Jan; 54():153-8. PubMed ID: 13764445 [No Abstract] [Full Text] [Related]
20. Accidental acute dilantin poisoning; report of a case with complete recovery in a nonepileptic child. PRICE WC; FRANK ME J Pediatr; 1950 May; 36(5):652-5. PubMed ID: 15415848 [No Abstract] [Full Text] [Related] [Next] [New Search]